264 related articles for article (PubMed ID: 30046007)
21. Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.
Shen S; Saito Y; Ren S; Liu C; Guo T; Qualliotine J; Khan Z; Sadat S; Califano JA
Otolaryngol Head Neck Surg; 2020 Apr; 162(4):512-519. PubMed ID: 32041482
[TBL] [Abstract][Full Text] [Related]
22. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
23. The New Face of Head and Neck Cancer: The HPV Epidemic.
Lewis A; Kang R; Levine A; Maghami E
Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
[TBL] [Abstract][Full Text] [Related]
24. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
[TBL] [Abstract][Full Text] [Related]
25. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
26. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
[TBL] [Abstract][Full Text] [Related]
27. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
[TBL] [Abstract][Full Text] [Related]
29. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
[TBL] [Abstract][Full Text] [Related]
30. Estimating the conditional probability of developing human papilloma virus related oropharyngeal cancer by combining machine learning and inverse Bayesian modelling.
Tewari P; Kashdan E; Walsh C; Martin CM; Parnell AC; O'Leary JJ
PLoS Comput Biol; 2021 Aug; 17(8):e1009289. PubMed ID: 34415913
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence of human papillomavirus infection in squamous cell carcinoma of the oral cavity, oropharynx and larynx].
Villagómez-Ortíz VJ; Paz-Delgadillo DE; Marino-Martínez I; Ceseñas-Falcón LÁ; Sandoval-de la Fuente A; Reyes-Escobedo A
Cir Cir; 2016; 84(5):363-8. PubMed ID: 27032466
[TBL] [Abstract][Full Text] [Related]
32. Identifying patterns of failure and secondary primary malignancies in HPV-related oropharyngeal squamous cell carcinomas.
Holstead R; Rasul R; Golden A; Kamdar D; Ghaly M; Teckie S; Frank D; Fantasia J; Seetharamu N
Future Oncol; 2020 Feb; 16(6):199-207. PubMed ID: 31967480
[No Abstract] [Full Text] [Related]
33. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique.
Blumberg J; Monjane L; Prasad M; Carrilho C; Judson BL
Cancer Epidemiol; 2015 Dec; 39(6):1000-5. PubMed ID: 26590333
[TBL] [Abstract][Full Text] [Related]
35. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
[TBL] [Abstract][Full Text] [Related]
36. Ki67 Expression has Prognostic Significance in Relation to Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma.
Liu J; Zhang M; Rose B; Veillard AS; Jones D; Zhang X; Soon Lee C; Milross C; Hong A
Ann Surg Oncol; 2015; 22(6):1893-900. PubMed ID: 25404475
[TBL] [Abstract][Full Text] [Related]
37. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
[TBL] [Abstract][Full Text] [Related]
38. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
[TBL] [Abstract][Full Text] [Related]
39. The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis.
Rajasekaran K; Carey RM; Lin X; Seckar TD; Wei Z; Chorath K; Newman JG; O'Malley BW; Weinstein GS; Feldman MD; Robertson E
Oral Oncol; 2021 Jun; 117():105305. PubMed ID: 33905914
[TBL] [Abstract][Full Text] [Related]
40. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
